These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 25590214)

  • 1. Arterial norepinephrine concentration is inversely and independently associated with insulin clearance in obese individuals with metabolic syndrome.
    Straznicky NE; Grima MT; Lambert EA; Sari CI; Eikelis N; Nestel PJ; Phillips SE; Hering D; Karapanagiotidis S; Dixon JB; Schlaich MP; Lambert GW
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1544-50. PubMed ID: 25590214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pioglitazone treatment enhances the sympathetic nervous system response to oral carbohydrate load in obese individuals with metabolic syndrome.
    Straznicky NE; Grima MT; Sari CI; Eikelis N; Lambert GW; Nestel PJ; Richards K; Dixon JB; Schlaich MP; Lambert EA
    Metabolism; 2015 Jul; 64(7):797-803. PubMed ID: 25827058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relation of glucose metabolism to left ventricular mass and function and sympathetic nervous system activity in obese subjects with metabolic syndrome.
    Straznicky NE; Grima MT; Sari CI; Karapanagiotidis S; Wong C; Eikelis N; Richards KL; Lee G; Nestel PJ; Dixon JB; Lambert GW; Schlaich MP; Lambert EA
    J Clin Endocrinol Metab; 2013 Feb; 98(2):E227-37. PubMed ID: 23271752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction in peripheral vascular resistance predicts improvement in insulin clearance following weight loss.
    Straznicky NE; Grima MT; Sari CI; Lambert EA; Phillips SE; Eikelis N; Kobayashi D; Hering D; Mariani JA; Dixon JB; Nestel PJ; Karapanagiotidis S; Schlaich MP; Lambert GW
    Cardiovasc Diabetol; 2015 Aug; 14():113. PubMed ID: 26297500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized controlled trial of the effects of pioglitazone treatment on sympathetic nervous system activity and cardiovascular function in obese subjects with metabolic syndrome.
    Straznicky NE; Grima MT; Sari CI; Eikelis N; Lambert GW; Nestel PJ; Karapanagiotidis S; Wong C; Richards K; Marusic P; Dixon JB; Schlaich MP; Lambert EA
    J Clin Endocrinol Metab; 2014 Sep; 99(9):E1701-7. PubMed ID: 24937541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroadrenergic dysfunction along the diabetes continuum: a comparative study in obese metabolic syndrome subjects.
    Straznicky NE; Grima MT; Sari CI; Eikelis N; Lambert EA; Nestel PJ; Esler MD; Dixon JB; Chopra R; Tilbrook AJ; Schlaich MP; Lambert GW
    Diabetes; 2012 Oct; 61(10):2506-16. PubMed ID: 22664956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of fatty liver on insulin clearance and insulin resistance in non-diabetic Japanese subjects.
    Goto T; Onuma T; Takebe K; Kral JG
    Int J Obes Relat Metab Disord; 1995 Dec; 19(12):841-5. PubMed ID: 8963349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women?
    Brochu M; Tchernof A; Dionne IJ; Sites CK; Eltabbakh GH; Sims EA; Poehlman ET
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1020-5. PubMed ID: 11238480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clearance approach in hyperinsulinemic-euglycemic clamp evaluation in lean and obese subjects.
    Dedik L; Chrenova J; Rausova Z; Mingrone G; Penesova A
    Endocr Res; 2015; 40(3):156-9. PubMed ID: 25531505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measuring insulin sensitivity in postmenopausal women covering a range of glucose tolerance: comparison of indices derived from the oral glucose tolerance test with the euglycemic-hyperinsulinemic clamp.
    Piché ME; Lemieux S; Corneau L; Nadeau A; Bergeron J; Weisnagel SJ
    Metabolism; 2007 Sep; 56(9):1159-66. PubMed ID: 17697856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-body glycolysis measured by the deuterated-glucose disposal test correlates highly with insulin resistance in vivo.
    Beysen C; Murphy EJ; McLaughlin T; Riiff T; Lamendola C; Turner HC; Awada M; Turner SM; Reaven G; Hellerstein MK
    Diabetes Care; 2007 May; 30(5):1143-9. PubMed ID: 17259480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased serum interleukin-18 concentration is associated with hypoadiponectinemia in obesity, independently of insulin resistance.
    Straczkowski M; Kowalska I; Nikolajuk A; Otziomek E; Adamska A; Karolczuk-Zarachowicz M; Gorska M
    Int J Obes (Lond); 2007 Feb; 31(2):221-5. PubMed ID: 16770329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying metabolically healthy but obese individuals in sedentary postmenopausal women.
    Messier V; Karelis AD; Prud'homme D; Primeau V; Brochu M; Rabasa-Lhoret R
    Obesity (Silver Spring); 2010 May; 18(5):911-7. PubMed ID: 19851302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of indices of insulin resistance with metabolic syndrome classifications to predict the development of impaired fasting glucose in overweight and obese subjects: a 3-year prospective study.
    Shand BI; Scott RS; Lewis JG; Elder PA; Frampton CM
    Int J Obes (Lond); 2009 Nov; 33(11):1274-9. PubMed ID: 19721448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blunted sympathetic neural response to oral glucose in obese subjects with the insulin-resistant metabolic syndrome.
    Straznicky NE; Lambert GW; Masuo K; Dawood T; Eikelis N; Nestel PJ; McGrane MT; Mariani JA; Socratous F; Chopra R; Esler MD; Schlaich MP; Lambert EA
    Am J Clin Nutr; 2009 Jan; 89(1):27-36. PubMed ID: 19056585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships between desacylated and acylated ghrelin and insulin sensitivity in the metabolic syndrome.
    Barazzoni R; Zanetti M; Ferreira C; Vinci P; Pirulli A; Mucci M; Dore F; Fonda M; Ciocchi B; Cattin L; Guarnieri G
    J Clin Endocrinol Metab; 2007 Oct; 92(10):3935-40. PubMed ID: 17652221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic kidney disease and obesity bias surrogate estimates of insulin sensitivity compared with the hyperinsulinemic euglycemic clamp.
    Ahmad I; Zelnick LR; Robinson NR; Hung AM; Kestenbaum B; Utzschneider KM; Kahn SE; de Boer IH
    Am J Physiol Endocrinol Metab; 2017 Mar; 312(3):E175-E182. PubMed ID: 28073780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased non-insulin-dependent glucose clearance contributes to the rise in fasting plasma glucose in the nondiabetic range.
    Jani R; Molina M; Matsuda M; Balas B; Chavez A; DeFronzo RA; Abdul-Ghani M
    Diabetes Care; 2008 Feb; 31(2):311-5. PubMed ID: 18000182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Clamp-Like Index: a novel and highly sensitive insulin sensitivity index to calculate hyperinsulinemic clamp glucose infusion rates from oral glucose tolerance tests in nondiabetic subjects.
    Anderwald C; Anderwald-Stadler M; Promintzer M; Prager G; Mandl M; Nowotny P; Bischof MG; Wolzt M; Ludvik B; Kästenbauer T; Pacini G; Luger A; Krebs M
    Diabetes Care; 2007 Sep; 30(9):2374-80. PubMed ID: 17595351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between several insulin sensitivity indices and metabolic risk factors in overweight and obese postmenopausal women: a MONET study.
    Malita FM; Messier V; Lavoie JM; Bastard JP; Rabasa-Lhoret R; Karelis AD
    Nutr Metab Cardiovasc Dis; 2010 Mar; 20(3):173-9. PubMed ID: 19501492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.